chlamydia

This Week in PLOS

In PLOS this week: genetic diversity of Trypanosoma cruzi, sequencing analysis of Chlamydia from turtles, and more.

The clinic, a partnership of the Florida Department of Health in Broward County and the AIDS Healthcare Foundation hopes to improve STD treatment and control.

In Genome Research this week: population genomics and genome dynamics of Chlamydia, non-coding mutation found in microcephaly-micromelia syndrome, and more.

While molecular testing is now routine in cancer and women's health, for other disease areas, the technology may be overkill, Sundin said. 

The firm recently won an NIH grant to develop its instrument-free gonorrhea test, and is also developing a chlamydia assay with the long-term goal of making a combined CT/NG test.

The test runs on the firm's high throughput platforms and has claims for extragenital samples in addition to traditional samples.

Solid MDx revenue growth was driven primarily by sales of Aptima women's health products on the Panther and Tigris platforms.

A koala genome bank aims to increase healthy genes in its population and reduce chlamydia infections, according to Australian Geographic.

The test detects chlamydia, gonorrhea, and trichomonas from a single patient sample.

Revenues from the company’s molecular diagnostics business grew 6 percent, driven by continued strength in sales of women's health products.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.